MedPath
FDA Approval

Carvedilol

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 11, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Carvedilol(25 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Beximco Pharmaceuticals Ltd

Bayshore Pharmaceuticals LLC

Beximco Pharmaceuticals USA Inc

731579053

Products4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Carvedilol

Product Details

NDC Product Code
76385-113
Application Number
ANDA078384
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
April 26, 2019
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
Code: 0K47UL67F2Class: ACTIBQuantity: 25 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
SODIUM CITRATEInactive
Code: 1Q73Q2JULRClass: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT

Carvedilol

Product Details

NDC Product Code
76385-110
Application Number
ANDA078384
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
April 26, 2019
SODIUM CITRATEInactive
Code: 1Q73Q2JULRClass: IACT
Code: 0K47UL67F2Class: ACTIBQuantity: 3.125 mg in 1 1
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT

Carvedilol

Product Details

NDC Product Code
76385-112
Application Number
ANDA078384
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
April 26, 2019
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
SODIUM CITRATEInactive
Code: 1Q73Q2JULRClass: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
Code: 0K47UL67F2Class: ACTIBQuantity: 12.5 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT

Carvedilol

Product Details

NDC Product Code
76385-111
Application Number
ANDA078384
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
April 26, 2019
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
Code: 0K47UL67F2Class: ACTIBQuantity: 6.25 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
SODIUM CITRATEInactive
Code: 1Q73Q2JULRClass: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
© Copyright 2025. All Rights Reserved by MedPath